Sources | Names Used |
---|---|
CCLE, GDSC1000, FIMM | Nilotinib |
CTRPv2 | nilotinib |
PharmacoGx | Nilotinib |
Database | Identifier |
---|---|
Smiles: | CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5 |
Inchikey: | HHZIURLSWUIHRB-UHFFFAOYSA-N |
Pubchem: | 644241 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RFESD | CTRPv2 | pan-cancer | AAC | 0.31 | 7e-17 |
mRNA | GFI1B | CTRPv2 | pan-cancer | AAC | 0.3 | 9e-17 |
mRNA | ADAT2 | CTRPv2 | pan-cancer | AAC | 0.35 | 1e-16 |
mRNA | HBG2 | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-16 |
mRNA | SAMSN1 | CTRPv2 | pan-cancer | AAC | 0.32 | 2e-16 |
mRNA | HBG1 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-16 |
mRNA | RHAG | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-16 |
mRNA | HDC | GDSC1000 | pan-cancer | AAC | 0.29 | 2e-16 |
mRNA | ZNF175 | GDSC1000 | pan-cancer | AAC | 0.3 | 4e-16 |
mRNA | EGFL7 | GDSC1000 | pan-cancer | AAC | 0.29 | 4e-16 |